The stock of ClearPoint Neuro Inc (CLPT) has gone down by -6.47% for the week, with a 7.71% rise in the past month and a -31.06% drop in the past quarter. The volatility ratio for the week is 10.13%, and the volatility levels for the past 30 days are 7.18% for CLPT. The simple moving average for the past 20 days is -8.53% for CLPT’s stock, with a -6.02% simple moving average for the past 200 days.
Is It Worth Investing in ClearPoint Neuro Inc (NASDAQ: CLPT) Right Now?
Moreover, the 36-month beta value for CLPT is 1.00. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CLPT is 24.08M and currently, short sellers hold a 4.43% of that float. On May 15, 2025, CLPT’s average trading volume was 263.33K shares.
CLPT) stock’s latest price update
ClearPoint Neuro Inc (NASDAQ: CLPT) has experienced a decline in its stock price by -12.46 compared to its previous closing price of 14.20. However, the company has seen a fall of -6.47% in its stock price over the last five trading days. seekingalpha.com reported 2025-05-13 that ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Joseph Burnett – President and Chief Executive Officer Danilo D’Alessandro – Chief Financial Officer Conference Call Participants Mathew Blackman – Stifel Frank Takkinen – Lake Street Capital Markets Anderson Schock – B. Riley Securities Operator Greetings and welcome to ClearPoint Neuro, Inc. First Quarter 2025 Financial Results Conference Call.
Analysts’ Opinion of CLPT
Many brokerage firms have already submitted their reports for CLPT stocks, with B. Riley Securities repeating the rating for CLPT by listing it as a “Buy.” The predicted price for CLPT in the upcoming period, according to B. Riley Securities is $10 based on the research report published on July 25, 2024 of the previous year 2024.
Stifel, on the other hand, stated in their research note that they expect to see CLPT reach a price target of $8. The rating they have provided for CLPT stocks is “Buy” according to the report published on October 24th, 2023.
B. Riley Securities gave a rating of “Buy” to CLPT, setting the target price at $14 in the report published on February 16th of the previous year.
CLPT Trading at -4.02% from the 50-Day Moving Average
After a stumble in the market that brought CLPT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -35.33% of loss for the given period.
Volatility was left at 7.18%, however, over the last 30 days, the volatility rate increased by 10.13%, as shares surge +5.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.31% lower at present.
During the last 5 trading sessions, CLPT fell by -6.47%, which changed the moving average for the period of 200-days by +68.20% in comparison to the 20-day moving average, which settled at $13.59. In addition, ClearPoint Neuro Inc saw -19.18% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CLPT
Current profitability levels for the company are sitting at:
- -0.63 for the present operating margin
- 0.61 for the gross margin
The net margin for ClearPoint Neuro Inc stands at -0.6. The total capital return value is set at -0.68. Equity return is now at value -76.21, with -49.68 for asset returns.
Based on ClearPoint Neuro Inc (CLPT), the company’s capital structure generated 0.12 points at debt to capital in total, while cash flow to debt ratio is standing at -2.51.
Currently, EBITDA for the company is -17.84 million with net debt to EBITDA at 0.91. When we switch over and look at the enterprise to sales, we see a ratio of 10.55. The receivables turnover for the company is 6.66for trailing twelve months and the total asset turnover is 0.8. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.51.
Conclusion
To wrap up, the performance of ClearPoint Neuro Inc (CLPT) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
